You are head of a pharmaceutical R&D firm. Research has brought to you two drugs for the treatment of a disease. The major difference between the drugs is that one is significantly metabolized by two CYP P450 enzymes while the other is metabolized by only one CYP enzyme. Based on this data decide which drug to take to clinical trials (a $100,000,000 decision) and defend your choice. List three questions you might ask your researchers. Explain why they are important criteria for making a decision.

Phlebotomy Essentials
6th Edition
ISBN:9781451194524
Author:Ruth McCall, Cathee M. Tankersley MT(ASCP)
Publisher:Ruth McCall, Cathee M. Tankersley MT(ASCP)
Chapter1: Phlebotomy: Past And Present And The Healthcare Setting
Section: Chapter Questions
Problem 1SRQ
icon
Related questions
Question
FOR ACADEMIC PURPOSES ONLY - NOT FOR CLINICAL USE
Test Details
Gene
Genotype
Phenotype
Alleles Tested
CYP2C19
*2/*7
Poor Metabolizer
*2, *3, *4, *48, *5, *6, *7, *8, *9, *17
CYP2D6
*1/4
Intermediate Metabolizer
*2, *3, *4, *4M, "6, *7, *8, *9, *10, *12, *14A, *148, *17, *29,
*35, *41
CYP3AS
*3/*3
Poor Metabolizer
*1D, *2, *3, *38, *3C, "6, *7, "8, *9
CYP3A4
*1/*1
Normal Metabolizer
*18, *2, *3, *12, *17, *22
VKORCI
-1639G>A G/A
Intermediate Warfarin Sensitivity
-1639G>A
*2, *3
*2, *3, *4, *5, "6, *11
CYP4F2
*1/3
Decreased Function
CYP2C9
*1/*1
Normal Metabolizer
CYP2B6
*1/*1
Normal Metabolizer
*6, *9
Normal Metabolizer - Higher
Inducibility
CYPIA2
*1F/"1F
*1C, *1D, *1F, *1K, *1L, *1V, *1W
SLCOIB1
521T>CT/T
Normal Function
521T>C, 388A>G
CFTR
F508del/RS53X
Negative
Numerous
DPYD
*1/*1
Normal Metabolizer
Numerous
ТРМТ
*1/*3A
*1/1
Intermediate Metabolizer
Normal Metabolizer
*2, *3A, *38, *3C, *4
*2, *3, *4, *5, "6, *7, *8, *9
NUDT15
UGTIAI
*1/*36
Normal Metabolizer
*6, *27, *28, *36, *37, *60, "80
G6PD Bangkok or Bangkok/
Bangkok
Deficient with CNSHA
Numerous
Additional Test Results (added to this original report)
HLA-A*31:01 negative/negative Negative
HLA-B'15:02 negative/negative Negative
HLA-B'57:01 negative/negative Negative
HLA-B'58.01 negative/negative Negative
You are head of a pharmaceutical R&D firm. Research has brought to you two drugs for the
treatment of a disease. The major difference between the drugs is that one is significantly
metabolized by two CYP P450 enzymes while the other is metabolized by only one CYP enzyme.
Based on this data decide which drug to take to clinical trials (a $100,000,000 decision) and defend
your choice. List three questions you might ask your researchers. Explain why they are important
criteria for making a decision.
Transcribed Image Text:FOR ACADEMIC PURPOSES ONLY - NOT FOR CLINICAL USE Test Details Gene Genotype Phenotype Alleles Tested CYP2C19 *2/*7 Poor Metabolizer *2, *3, *4, *48, *5, *6, *7, *8, *9, *17 CYP2D6 *1/4 Intermediate Metabolizer *2, *3, *4, *4M, "6, *7, *8, *9, *10, *12, *14A, *148, *17, *29, *35, *41 CYP3AS *3/*3 Poor Metabolizer *1D, *2, *3, *38, *3C, "6, *7, "8, *9 CYP3A4 *1/*1 Normal Metabolizer *18, *2, *3, *12, *17, *22 VKORCI -1639G>A G/A Intermediate Warfarin Sensitivity -1639G>A *2, *3 *2, *3, *4, *5, "6, *11 CYP4F2 *1/3 Decreased Function CYP2C9 *1/*1 Normal Metabolizer CYP2B6 *1/*1 Normal Metabolizer *6, *9 Normal Metabolizer - Higher Inducibility CYPIA2 *1F/"1F *1C, *1D, *1F, *1K, *1L, *1V, *1W SLCOIB1 521T>CT/T Normal Function 521T>C, 388A>G CFTR F508del/RS53X Negative Numerous DPYD *1/*1 Normal Metabolizer Numerous ТРМТ *1/*3A *1/1 Intermediate Metabolizer Normal Metabolizer *2, *3A, *38, *3C, *4 *2, *3, *4, *5, "6, *7, *8, *9 NUDT15 UGTIAI *1/*36 Normal Metabolizer *6, *27, *28, *36, *37, *60, "80 G6PD Bangkok or Bangkok/ Bangkok Deficient with CNSHA Numerous Additional Test Results (added to this original report) HLA-A*31:01 negative/negative Negative HLA-B'15:02 negative/negative Negative HLA-B'57:01 negative/negative Negative HLA-B'58.01 negative/negative Negative You are head of a pharmaceutical R&D firm. Research has brought to you two drugs for the treatment of a disease. The major difference between the drugs is that one is significantly metabolized by two CYP P450 enzymes while the other is metabolized by only one CYP enzyme. Based on this data decide which drug to take to clinical trials (a $100,000,000 decision) and defend your choice. List three questions you might ask your researchers. Explain why they are important criteria for making a decision.
Expert Solution
trending now

Trending now

This is a popular solution!

steps

Step by step

Solved in 2 steps

Blurred answer
Knowledge Booster
Metabolic pathways
Learn more about
Need a deep-dive on the concept behind this application? Look no further. Learn more about this topic, nursing and related others by exploring similar questions and additional content below.
Similar questions
  • SEE MORE QUESTIONS
Recommended textbooks for you
Phlebotomy Essentials
Phlebotomy Essentials
Nursing
ISBN:
9781451194524
Author:
Ruth McCall, Cathee M. Tankersley MT(ASCP)
Publisher:
JONES+BARTLETT PUBLISHERS, INC.
Gould's Pathophysiology for the Health Profession…
Gould's Pathophysiology for the Health Profession…
Nursing
ISBN:
9780323414425
Author:
Robert J Hubert BS
Publisher:
Saunders
Fundamentals Of Nursing
Fundamentals Of Nursing
Nursing
ISBN:
9781496362179
Author:
Taylor, Carol (carol R.), LYNN, Pamela (pamela Barbara), Bartlett, Jennifer L.
Publisher:
Wolters Kluwer,
Fundamentals of Nursing, 9e
Fundamentals of Nursing, 9e
Nursing
ISBN:
9780323327404
Author:
Patricia A. Potter RN MSN PhD FAAN, Anne Griffin Perry RN EdD FAAN, Patricia Stockert RN BSN MS PhD, Amy Hall RN BSN MS PhD CNE
Publisher:
Elsevier Science
Study Guide for Gould's Pathophysiology for the H…
Study Guide for Gould's Pathophysiology for the H…
Nursing
ISBN:
9780323414142
Author:
Hubert BS, Robert J; VanMeter PhD, Karin C.
Publisher:
Saunders
Issues and Ethics in the Helping Professions (Min…
Issues and Ethics in the Helping Professions (Min…
Nursing
ISBN:
9781337406291
Author:
Gerald Corey, Marianne Schneider Corey, Cindy Corey
Publisher:
Cengage Learning